Literature DB >> 7114371

Endotoxemia, disturbance of coagulation, and obstructive jaundice.

D R Hunt, M E Allison, C R Prentice, L H Blumgart.   

Abstract

A prospective study of coagulation disturbances and endotoxemia in 42 patients having major pancreatic or biliary surgery was performed. Endotoxin, soluble fibrin, and fibrin degradation products were measured before and after operation in 28 patients with obstructive jaundice and in 14 nonjaundiced controls. In the control group there was one death and no unexplained fever or postoperative hemorrhage. The jaundiced group had more complications: seven deaths, nine episodes of fever, and six episodes of hemorrhage. Soluble fibrin was detected only in patients with obstructive jaundice, in whom it occurred in 38 percent before operation. Positive endotoxin assay was as common in control patients as in the jaundiced group, but in the latter endotoxin was associated (p less than 0.05) with increased FDP and soluble fibrin. Patients with endotoxin or increased FDP levels before operation for jaundice carry a poor prognosis (7 of 11 died). Preoperative bowel preparation in 16 of the jaundiced patients did not affect the outcome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114371     DOI: 10.1016/0002-9610(82)90011-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  The role of preoperative biliary decompression in the treatment of bile duct cancer.

Authors:  J Yanagisawa; H Ichimiya; N Kuwano; F Nakayama
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

2.  Value of preoperative biliary drainage in a consecutive series of resectable periampullary lesions. From randomized studies to real medical practice.

Authors:  Jumpol Singhirunnusorn; Lebeau Roger; Xavier Chopin-Laly; Vincent Lepilliez; Thierry Ponchon; Mustapha Adham
Journal:  Langenbecks Arch Surg       Date:  2012-09-25       Impact factor: 3.445

3.  Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.

Authors:  Xin Lv; Jian-Gang Song; Hong-Hai Li; Jun-Ping Ao; Ping Zhang; Ye-Sheng Li; Shao-Li Song; Xiang-Rui Wang
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

4.  Hemorrhage after pancreatoduodenectomy.

Authors:  B Rumstadt; M Schwab; P Korth; M Samman; M Trede
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

5.  Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

Authors:  H A Pitt; A S Gomes; J F Lois; L L Mann; L S Deutsch; W P Longmire
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

6.  Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.

Authors:  W D Clements; M McCaigue; P Erwin; I Halliday; B J Rowlands
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

7.  Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.

Authors:  R M Beazley; N Hadjis; I S Benjamin; L H Blumgart
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

Review 8.  A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Authors:  Miguel E Sewnath; Thomas M Karsten; Martin H Prins; Erik J A Rauws; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

9.  Alterations of tumor necrosis factor-alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental obstructive jaundice in rats.

Authors:  Janusz Dawiskiba; Pawel Kornafel; Danuta Kwiatkowska; Michal Zimecki
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

10.  Effects of n-3 Fatty Acids Supplementation on Plasma Phospholipids Fatty Acid Composition in Patients with Obstructive Jaundice- a Pilot Study.

Authors:  Tamara Popovic; Marija Ranic; Predrag Bulajic; Miroslav Milicevic; Aleksandra Arsic; Vesna Vucic; Marija Glibetic
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.